InteRNA presents data on potential of lead oncology development candidate INT-1B3 in immuno-oncology at the SelectBIO Immuno-Oncology Europe 2019 meeting

31 October, 2019

InteRNA presents data on potential of lead oncology development candidate INT-1B3 in immuno-oncology at the SelectBIO Immuno-Oncology Europe 2019 meeting

Please click here to read InteRNA Poster showing the data

EVENTS

08 April 2020 - 10 April 2020

16th European Symposium on Controlled Drug Delivery (ESCDD), Egmond aan Zee, The Netherlands

05 May 2020 - 07 May 2020

18th CIMT Annual Meeting, Mainz, Germany

07 May 2020 - 09 May 2020

ESMO Breast Cancer 2020, Berlin, Germany

NEWS

25 March, 2020

InteRNA steunt de campagne Innovaties in Oncologie van @Mediaplanet. Leer meer over verschillende innovaties in oncologie zoals immuuntherapieën van thought leaders, zoals Ton Schumacher online of in de New Scientist (24 maart 2020)

31 October, 2019

InteRNA presents data on potential of lead oncology development candidate INT-1B3 in immuno-oncology at the SelectBIO Immuno-Oncology Europe 2019 meeting

31 October, 2019

InteRNA presents data on drug formulation and mode of action of lead oncology development candidate INT-1B3 at the 15th annual OTS meeting

15 May, 2019

InteRNA and UMC Utrecht Publish Preclinical Evidence for Potential of miRNAs in Treatment of Epilepsy

25 March, 2019

InteRNA Appoints Andrea van Elsas, Ph.D. to Scientific Advisory Board

1-5 6-10 11-15 16-20 21-25 26-30 31-31